Home › Companies › Esperion Therapeutics, Inc. › 2024-2025
Compiled from SEC Form N-PX filings and Esperion Therapeutics, Inc.’s Form 8-K, filed 2025-06-02 (Item 5.07 on EDGAR). Page generated 04 October 2026.
Explore Esperion Therapeutics, Inc. in the interactive database Compare manager voting policies
These tallies are Esperion Therapeutics, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-02 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Jay P. Shepard | 75,821,767 | -- | -- | 23,071,427 | 37,575,467 | Majority: yes |
| Elect Director: Seth H.Z. Fischer | 83,336,719 | -- | -- | 15,556,475 | 37,575,467 | Majority: yes |
| The Company's stockholders approved Proposal 2. | 70,756,440 | 26,653,578 | 1,483,176 | -- | 37,575,467 | Majority: yes |
| The Company's stockholders approved Proposal 3. | 118,152,430 | 16,130,318 | 2,185,913 | -- | -- | Majority: yes |
| The Company's stockholders approved Proposal 4. | 75,390,791 | 22,685,588 | 816,815 | -- | 37,575,467 | Majority: yes |
Source: Esperion Therapeutics, Inc., Form 8-K, filed with the SEC on 2025-06-02 — read the filing on EDGAR.
Each item below shows how the 144 asset managers that disclosed a Esperion Therapeutics, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Esperion Therapeutics, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 3 wordings of this item as funds reported it.
90% fund support · no official result
The 142 asset managers below cast 90% of the shares they voted on this item FOR (64,847,658 for, 7,575,153 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| WASATCH ADVISORS LP | 9,771,807 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 8,264,814 | 0 | 0 | 0 | For |
| Vanguard | 7,827,685 | 0 | 0 | 0 | For |
| BlackRock | 6,937,950 | 15,208 | 0 | 0 | For |
| Two Seas Capital LP | 6,806,374 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 4,122,797 | 0 | 0 | 0 | For |
| Fidelity | 3,715,469 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 0 | 3,529,999 | 0 | 0 | Against |
| State Street | 3,170,204 | 966 | 0 | 0 | For |
| Indaba Capital Management, L.P. | 0 | 3,000,000 | 0 | 0 | Against |
| Two Sigma | 2,588,297 | 0 | 0 | 0 | For |
| PenderFund Capital Management Ltd. | 2,000,000 | 0 | 0 | 0 | For |
| Citadel | 910,069 | 0 | 0 | 0 | For |
| Woodline Partners LP | 906,810 | 0 | 0 | 0 | For |
| Northern Trust | 876,581 | 0 | 0 | 0 | For |
| Charles Schwab | 863,054 | 0 | 0 | 0 | For |
| Nuveen | 802,702 | 0 | 0 | 0 | For |
| TIAA | 794,539 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 603,350 | 0 | 0 | 0 | For |
| Connor, Clark & Lunn Investment Management Ltd. | 579,171 | 0 | 0 | 0 | For |
| Wellington | 0 | 553,694 | 0 | 0 | Against |
| Invesco | 402,848 | 0 | 0 | 0 | For |
| DE Shaw | 253,397 | 0 | 0 | 0 | For |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 0 | 0 | 222,482 | 0 | Abstain |
| Equitable | 213,472 | 0 | 0 | 0 | For |
Showing the 25 largest of 142 asset managers. See all 142 in the interactive database.
Combines 3 wordings of this item as funds reported it.
77% Majority: yes · of votes cast
Esperion Therapeutics, Inc.’s own tally for this item (“Elect Director: Jay P. Shepard”): 75,821,767 for, 23,071,427 withheld, per its Form 8-K filed 2025-06-02 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 189,460,293 outstanding shares: 40% for, 12% withheld (52.2% of the company cast a for/withheld vote).
The 36 asset managers below cast 100% of the shares they voted on this item FOR (23,906,982 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| WASATCH FUNDS TRUST | 8,264,814 | 0 | 0 | 0 | For |
| Vanguard | 7,711,521 | 0 | 0 | 0 | For |
| Fidelity | 3,702,644 | 0 | 0 | 0 | For |
| BlackRock | 3,347,621 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 794,539 | 0 | Abstain |
| Charles Schwab | 0 | 0 | 431,527 | 0 | Abstain |
| Equitable | 54,212 | 0 | 159,260 | 0 | Abstain |
| State Street | 531 | 0 | 185,958 | 0 | Abstain |
| Invesco | 0 | 0 | 162,539 | 0 | Abstain |
| ETFis Series Trust I | 140,800 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 0 | 140,100 | 0 | Abstain |
| Northern Trust | 0 | 0 | 90,862 | 0 | Abstain |
| ProShares | 89,094 | 0 | 0 | 0 | For |
| Pacific Life | 84,096 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 79,571 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 71,755 | 0 | 0 | 0 | For |
| John Hancock | 67,549 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 52,766 | 0 | Abstain |
| Brighthouse | 43,205 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 40,608 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 40,100 | 0 | 0 | 0 | For |
| Jacob Funds Inc. | 31,497 | 0 | 0 | 0 | For |
| SEI | 31,100 | 0 | 0 | 0 | For |
| DWS | 29,757 | 0 | 0 | 0 | For |
| Global X | 29,749 | 0 | 0 | 0 | For |
Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.
Combines 3 wordings of this item as funds reported it.
84% Majority: yes · of votes cast
Esperion Therapeutics, Inc.’s own tally for this item (“Elect Director: Seth H.Z. Fischer”): 83,336,719 for, 15,556,475 withheld, per its Form 8-K filed 2025-06-02 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 189,460,293 outstanding shares: 44% for, 8% withheld (52.2% of the company cast a for/withheld vote).
The 36 asset managers below cast 100% of the shares they voted on this item FOR (25,942,042 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| WASATCH FUNDS TRUST | 8,264,814 | 0 | 0 | 0 | For |
| Vanguard | 7,711,521 | 0 | 0 | 0 | For |
| Fidelity | 3,702,644 | 0 | 0 | 0 | For |
| BlackRock | 3,347,621 | 0 | 0 | 0 | For |
| TIAA | 794,539 | 0 | 0 | 0 | For |
| Charles Schwab | 431,527 | 0 | 0 | 0 | For |
| Equitable | 213,472 | 0 | 0 | 0 | For |
| State Street | 186,489 | 0 | 0 | 0 | For |
| Invesco | 162,539 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 140,800 | 0 | 0 | 0 | For |
| Lincoln Financial | 140,100 | 0 | 0 | 0 | For |
| Northern Trust | 90,862 | 0 | 0 | 0 | For |
| ProShares | 89,094 | 0 | 0 | 0 | For |
| Pacific Life | 84,096 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 79,571 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 71,755 | 0 | 0 | 0 | For |
| John Hancock | 67,549 | 0 | 0 | 0 | For |
| Voya | 52,766 | 0 | 0 | 0 | For |
| Brighthouse | 43,205 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 40,608 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 40,100 | 0 | 0 | 0 | For |
| Jacob Funds Inc. | 31,497 | 0 | 0 | 0 | For |
| SEI | 31,100 | 0 | 0 | 0 | For |
| DWS | 29,757 | 0 | 0 | 0 | For |
| Global X | 29,749 | 0 | 0 | 0 | For |
Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.
99.9% fund support · no official result
The 36 asset managers below cast 99.9% of the shares they voted on this item FOR (25,957,750 for, 2,804 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| WASATCH FUNDS TRUST | 8,264,814 | 0 | 0 | 0 | For |
| Vanguard | 7,711,521 | 0 | 0 | 0 | For |
| Fidelity | 3,702,644 | 0 | 0 | 0 | For |
| BlackRock | 3,347,621 | 0 | 0 | 0 | For |
| TIAA | 794,539 | 0 | 0 | 0 | For |
| Charles Schwab | 431,527 | 0 | 0 | 0 | For |
| Equitable | 213,472 | 0 | 0 | 0 | For |
| State Street | 186,462 | 27 | 0 | 0 | For |
| Invesco | 162,539 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 140,800 | 0 | 0 | 0 | For |
| Lincoln Financial | 140,100 | 0 | 0 | 0 | For |
| Northern Trust | 90,862 | 0 | 0 | 0 | For |
| ProShares | 89,094 | 0 | 0 | 0 | For |
| Pacific Life | 84,096 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 79,571 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 71,755 | 0 | 0 | 0 | For |
| John Hancock | 67,549 | 0 | 0 | 0 | For |
| Voya | 52,766 | 0 | 0 | 0 | For |
| Brighthouse | 43,205 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 40,608 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 40,100 | 0 | 0 | 0 | For |
| Jacob Funds Inc. | 28,720 | 2,777 | 0 | 0 | For |
| SEI | 31,100 | 0 | 0 | 0 | For |
| DWS | 29,757 | 0 | 0 | 0 | For |
| Global X | 29,749 | 0 | 0 | 0 | For |
Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.
99.9% fund support · no official result
The 36 asset managers below cast 99.9% of the shares they voted on this item FOR (25,960,527 for, 27 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| WASATCH FUNDS TRUST | 8,264,814 | 0 | 0 | 0 | For |
| Vanguard | 7,711,521 | 0 | 0 | 0 | For |
| Fidelity | 3,702,644 | 0 | 0 | 0 | For |
| BlackRock | 3,347,621 | 0 | 0 | 0 | For |
| TIAA | 794,539 | 0 | 0 | 0 | For |
| Charles Schwab | 431,527 | 0 | 0 | 0 | For |
| Equitable | 213,472 | 0 | 0 | 0 | For |
| State Street | 186,462 | 27 | 0 | 0 | For |
| Invesco | 162,539 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 140,800 | 0 | 0 | 0 | For |
| Lincoln Financial | 140,100 | 0 | 0 | 0 | For |
| Northern Trust | 90,862 | 0 | 0 | 0 | For |
| ProShares | 89,094 | 0 | 0 | 0 | For |
| Pacific Life | 84,096 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 79,571 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 71,755 | 0 | 0 | 0 | For |
| John Hancock | 67,549 | 0 | 0 | 0 | For |
| Voya | 52,766 | 0 | 0 | 0 | For |
| Brighthouse | 43,205 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 40,608 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 40,100 | 0 | 0 | 0 | For |
| Jacob Funds Inc. | 31,497 | 0 | 0 | 0 | For |
| SEI | 31,100 | 0 | 0 | 0 | For |
| DWS | 29,757 | 0 | 0 | 0 | For |
| Global X | 29,749 | 0 | 0 | 0 | For |
Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.
100% fund support · no official result
The 2 asset managers below cast 100% of the shares they voted on this item FOR (89,419 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JPMorgan | 89,360 | 0 | 0 | 0 | For |
| TD Waterhouse Canada Inc. | 59 | 0 | 0 | 0 | For |
Ranked by the number of Esperion Therapeutics, Inc. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 189,460,293 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | WASATCH ADVISORS LP | 5.16% |
| 2 | WASATCH FUNDS TRUST | 4.36% |
| 3 | Vanguard | 4.13% |
| 4 | BlackRock | 3.67% |
| 5 | Two Seas Capital LP | 3.59% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 2.18% |
| 7 | Fidelity | 1.96% |
| 8 | MARSHALL WACE, LLP | 1.86% |
| 9 | State Street | 1.67% |
| 10 | Indaba Capital Management, L.P. | 1.58% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Glazer Capital, LLC | 11.07% | 13G |
| BlackRock | 7.65% | 13F |
| Vanguard Group | 6.06% | 13F |
| BB Biotech AG | 5.12% | 13G |
| Morgan Stanley | 3.48% | 13F |
| State Street | 2.40% | 13F |
| Nuveen | 1.65% | 13F |
| Two Sigma | 1.44% | 13F |
| Citadel Advisors | 1.37% | 13F |
| JPMorgan Chase | 1.01% | 13F |
Percentages above are of 189,460,293 shares outstanding, as reported by Esperion Therapeutics, Inc. on its Form 10-Q dated 2024-05-01 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Esperion Therapeutics, Inc.’s 10-Q dated 2024-05-01. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.
At Esperion Therapeutics, Inc.'s shareholder meeting held 2025-05-29, in the 2024-2025 proxy season, 144 asset managers reported how they voted in their SEC Form N-PX filings, covering 677 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. Esperion Therapeutics, Inc.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To approve the non-binding advisory resolution on the compensation of our named executive… — the reporting funds cast 90% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.
Esperion Therapeutics, Inc. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.